Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy.

[1]  D. Elias,et al.  Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  T. Chua,et al.  Long-Term Survival in Patients with Pseudomyxoma Peritonei Treated with Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy: 10 Years of Experience from a Single Institution , 2009, Annals of Surgical Oncology.

[3]  K. Slim,et al.  Cancérologie digestive : pratiques chirurgicales , 2009 .

[4]  D. Elias,et al.  Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  D. Elias,et al.  Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy , 2008, The British journal of surgery.

[6]  T. McAvoy,et al.  Pseudomyxoma Peritonei: Is Disease Progression Related to Microbial Agents? A Study of Bacteria, MUC2 and MUC5AC Expression in Disseminated Peritoneal Adenomucinosis and Peritoneal Mucinous Carcinomatosis , 2008, Annals of Surgical Oncology.

[7]  F. Zoetmulder,et al.  Survival Analysis of Pseudomyxoma Peritonei Patients Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy , 2007, Annals of surgery.

[8]  P. Sugarbaker,et al.  A Systematic Review on the Efficacy of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei , 2007, Annals of Surgical Oncology.

[9]  P. Sugarbaker,et al.  Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer. , 2006, Journal of the American College of Surgeons.

[10]  K. Geisinger,et al.  Appendiceal Neoplasms With Peritoneal Dissemination: Outcomes After Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy , 2006, Annals of Surgical Oncology.

[11]  P. Sugarbaker.  New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? , 2006, The Lancet. Oncology.

[12]  D. Coit,et al.  Long-term Survival Following Treatment of Pseudomyxoma Peritonei: An Analysis of Surgical Therapy , 2005, Annals of surgery.

[13]  P. Sugarbaker,et al.  Incomplete Cytoreduction in 174 Patients With Peritoneal Carcinomatosis From Appendiceal Malignancy , 2004, Annals of surgery.

[14]  P. Sugarbaker,et al.  Right hemicolectomy does not confer a survival advantage in patients with mucinous carcinoma of the appendix and peritoneal seeding , 2004, The British journal of surgery.

[15]  A. Witkamp,et al.  Long-Term Survival of Peritoneal Carcinomatosis of Colorectal Origin , 2004, Annals of Surgical Oncology.

[16]  B. Moran,et al.  The etiology, clinical presentation, and management of pseudomyxoma peritonei. , 2003, Surgical oncology clinics of North America.

[17]  P. Sugarbaker.  Peritonectomy Procedures , 1995, Surgical oncology clinics of North America.

[18]  M. Ducreux,et al.  Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy , 2001, Cancer.

[19]  P. Sugarbaker,et al.  Results of Treatment of 385 Patients With Peritoneal Surface Spread of Appendiceal Malignancy , 1999, Annals of Surgical Oncology.

[20]  H. Kampinga,et al.  Reduction of cellular cisplatin resistance by hyperthermia--a review. , 1997, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[21]  P. H. Sugarbaker,et al.  Pseudomyxoma peritonei syndrome. , 1996, Advances in surgery.

[22]  R. Kurman,et al.  Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei". , 1995, The American journal of surgical pathology.

[23]  J. Donohue,et al.  Pseudomyxoma Peritonei Long‐Term Patient Survival with an Aggressive Regional Approach , 1994, Annals of surgery.

[24]  村上 篤信.  Thermochemosensitivity : augmentation by hyperthermia of cytotoxicity of anticancer drugs against human colorectal cancers, measured by the human tumor clonogenic assay , 1989 .

[25]  M. Maeta,et al.  Thermochemosensitivity: augmentation by hyperthermia of cytotoxicity of anticancer drugs against human colorectal cancers, measured by the human tumor clonogenic assay. , 1988, Oncology.

[26]  Y. Osaki,et al.  Treatment of implanted peritoneal cancer in rats by continuous hyperthermic peritoneal perfusion in combination with an anticancer drug. , 1984, Cancer research.